Edition:
United Kingdom

Unichem Laboratories Ltd (UNLB.NS)

UNLB.NS on National Stock Exchange of India

328.00INR
8:24am GMT
Change (% chg)

Rs-8.65 (-2.57%)
Prev Close
Rs336.65
Open
Rs337.30
Day's High
Rs337.55
Day's Low
Rs327.05
Volume
40,502
Avg. Vol
485,873
52-wk High
Rs382.00
52-wk Low
Rs231.00

Select another date:

Wed, Jan 10 2018

BRIEF-Unichem Laboratories Seeks Shareholders' Nod For Share Buyback Proposal

* SEEKS SHAREHOLDERS' NOD FOR SHARE BUYBACK PROPOSAL WORTH 8.86 BILLION RUPEES Source text - http://bit.ly/2mik1mO Further company coverage:

BRIEF-Unichem Labs Dec-qtr Profit Rises

* DEC QUARTER PROFIT 25.07 BILLION RUPEES VERSUS 261.1 MILLION RUPEES YEAR AGO

BRIEF-Unichem Laboratories To Consider Proposal To Buy-Back Shares Of Co

* SAYS TO CONSIDER PROPOSAL TO BUY-BACK SHARES OF CO Source text - http://bit.ly/2CxeEdf Further company coverage:

BRIEF-Torrent Pharma Completes Acquisition Of Branded Formulation Business Of Unichem Labs

* SAYS TORRENT PHARMACEUTICALS LIMITED COMPLETES ACQUISITION OF BRANDED FORMULATION BUSINESS OF UNICHEM LABORATORIES LIMITED Source text: http://bit.ly/2krSQVo Further company coverage:

Torrent Pharma to buy Unichem Labs' India business for $558 million

Torrent Pharmaceuticals said on Friday it would buy more than 120 brands from Unichem Laboratories in India and Nepal, and its manufacturing plant at Sikkim.

UPDATE 2-Torrent Pharma to buy Unichem Labs' India business for $558 mln

Nov 3 Torrent Pharmaceuticals said on Friday it would buy more than 120 brands from Unichem Laboratories in India and Nepal, and its manufacturing plant at Sikkim.

Torrent Pharma to buy Unichem Labs' India business for $558 mln

Nov 3 Torrent Pharmaceuticals said on Friday it would buy more than 120 brands of Unichem Laboratories in India and Nepal and its manufacturing plant at Sikkim.

BRIEF-‍Torrent Pharma buys branded business of India & Nepal from Unichem

* ‍Torrent Pharma acquires branded formulation business of India and Nepal of Unichem Laboratories Limited​

BRIEF-India's Unichem Laboratories Sept-qtr profit rises

* Sept quarter profit 458.2 million rupees versus profit of 205.2 million rupees year ago

BRIEF-Unichem Labs gets ANDA approval for Irbesartan and hydrochlorothiazide tablets

* Says gets ANDA approval from USFDA for irbesartan and hydrochlorothiazide tablets usp Source text for Eikon: Further company coverage:

Select another date: